System and method for monitoring or treating a health condition

• US 20060189857A1
• Filed: 04/27/2006
• Published: 08/24/2006
• Est. Priority Date: 05/18/2001
• Status: Abandoned Application

• Current Assignee: Spectro Incorporated (Spectro Scientific, Inc.)
• Original Assignee: Spectro Incorporated (Spectro Scientific, Inc.)
• Inventors: Smith, Alan, Marcus, Raulee, Faupel, Mark, Yang, Difei
• Application Number:
  US11/412,491
• Publication Number:
  US 20060189857A1
• Time in Patent Office: Days
• US Class Current: 600/309
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14514 using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/441 Skin evaluation, e.g. for skin disorder diagnosis
• CPC Class Codes: A61B 5/4839 combined with drug delivery

Abstract

The present invention relates to a system and method for monitoring or treating a health condition. The method can include accessing a biological fluid, evaluating an analyte in the fluid, presenting a measurement parameter based on the evaluation, and/or administering a treatment based on the evaluation. The measurement parameter can prompt administering a treatment. The system can include a fluid handling device, a display and/or alert device, and/or an administration device. This abstract is provided for searching purposes only and is not meant for construing the claims.

Claims

1. A method for treating a health condition, comprising:

accessing a source of biological fluid;

evaluating an analyte of the biological fluid; and

administering a treatment based on the evaluation.

2. The method of claim 1, wherein accessing comprises making an opening in a tissue.

3. The method of claim 2, wherein the tissue comprises stratum corneum.

4. The method of claim 1, wherein the biological fluid comprises interstitial fluid, blood, serum, plasma, lymph, sweat, urine, or a combination thereof.

5. The method of claim 4, wherein the biological fluid comprises interstitial fluid.

6. The method of claim 1, wherein evaluating comprises detecting the analyte, quantitating the analyte, or a combination thereof.

7. The method of claim 6, wherein quantitating comprises determining an amount of analyte relative to a predetermined threshold value.

8. The method of claim 6, wherein quantitating comprises determining an absolute amount of analyte.

9. The method of claim 6, wherein detecting comprises determining that an amount of analyte is greater than a predetermined threshold value or is less than a predetermined threshold value.

10. The method of claim 1, wherein the treatment comprises administering a therapeutic agent or adjusting a behavior.

11. The method of claim 10, wherein administering the therapeutic agent comprises topical administration, oral administration, subcutaneous administration, or a combination thereof.

12. The method of claim 11, comprising topical administration.

13. The method of claim 1, wherein the analyte comprise albumin, ALP, ALT, AST, bilirubin, calcium, carbon dioxide, chloride, chlorine, creatinine, glucose, lactate, lactic acid, blood urea nitrogen, uric acid, IL-1α

receptor antagonist, matrix metalloprotein-1, insulin-like growth factor-1, interleukin-1α

, interleukin-2, or a combination thereof.

14. The method of claim 1, comprising continuous or discontinuous accessing and evaluating.

15. The method of claim 1, further comprising:

presenting a measurement parameter.

16. The method of claim 15, wherein the measurement parameter comprises an amount of analyte relative to a predetermined threshold value, an absolute amount of analyte, a signal indicating an amount of analyte greater or less than a predetermined threshold value, or a combination thereof.

17. A method for treating a health condition, comprising:

accessing a source of biological fluid;

evaluating an analyte of the biological fluid; and

presenting a measurement parameter based on the evaluation.

18. The method of claim 17, wherein accessing comprises making an opening in a tissue.

19. The method of claim 18, wherein the tissue comprises stratum corneum.

20. The method of claim 17, wherein the biological fluid comprises interstitial fluid, blood, serum, plasma, lymph, sweat, urine, or a combination thereof.

21. The method of claim 20, wherein the biological fluid comprises interstitial fluid.

22. The method of claim 17, wherein evaluating comprises detecting the analyte, quantitating the analyte, or a combination thereof.

23. The method of claim 22, wherein quantitating comprises determining an amount of analyte relative to a predetermined threshold value.

24. The method of claim 22, wherein quantitating comprises determining an absolute amount of analyte.

25. The method of claim 22, wherein detecting comprises determining that an amount of analyte is greater than a predetermined threshold value or is less than a predetermined threshold value.

26. The method of claim 17, wherein the measurement parameter comprises an amount of analyte relative to a predetermined threshold value, an absolute amount of analyte, a signal indicating an amount of analyte greater or less than a predetermined threshold value, or a combination thereof.

27. The method of claim 17, wherein presenting comprises alerting a subject or caregiver to the measurement parameter and to a need for administering a treatment.

28. The method of claim 17, wherein the analyte comprise albumin, ALP, ALT, AST, bilirubin, calcium, carbon dioxide, chloride, chlorine, creatinine, glucose, lactate, lactic acid, blood urea nitrogen, uric acid, IL-1α

receptor antagonist, matrix metalloprotein-1, insulin-like growth factor-1, interleukin-1α

, interleukin-2, or a combination thereof

29. The method of claim 17, comprising continuous or discontinuous accessing, evaluating, presenting, or a combination thereof

30. The method of claim 17, further comprising:

administering a treatment based on the evaluation.

31. The method of claim 30, wherein the treatment comprises administering a therapeutic agent or adjusting a behavior.

32. The method of claim 31, wherein administering the therapeutic agent comprises topical administration, oral administration, subcutaneous administration, or a combination thereof.

33. A system for treating a health condition, the system comprising:

a fluid handling device adapted and configured to obtain a biological fluid with an analyte and to evaluate the analyte;

a display and alert device adapted and configured to display the evaluation of the analyte and alert a user to the evaluation; and

an administration device adapted and configured to administer a therapy.

34. The system of claim 33, wherein the display and alert device comprises a display subdevice and an alert subdevice.

35. The system of claim 33, wherein the liquid handling device is adapted and configured to obtain a sample or interstitial fluid and quantitate an analyte in the interstitial fluid.